demonstrated by pretreatment of the target cells with F(ab')~ anti-Clq, which abrogated the cytotoxic effect (15) . Furthermore, monomeric C 1 q was reported to inhibit the collagen-dependent aggregation of platelets (19, 20) and the release of serotonin (21) . The importance of C lqR was not fully appreciated, partly because, in normal serum, Clq occurs as a subunit of the C1 complex. The amount of available free C 1 q was therefore thought to be very small. However, ClqR assumed new significance after it was observed that CT-INA, the plasma inhibitor of activated C 1, rapidly dissociates the activated C 1 r and C 1 s subunits from the C1 complex (22) , thus leaving Clq bound to immune complexes.
In previous reports (23, 24) , it was shown that a substance could be solubilized from membranes of lymphocytes or iymphoblastoid cells (Raji) that possesses the property of binding and precipitating free C 1 q, and hence was described as a C 1 q precipitin (23) or membrane-derived C 1 q inhibitor (M-C 1 qINH s) (24) . In the present study, evidence is presented demonstrating that this membranederived inhibitor constitutes the cellular receptor for C 1 q.
Materials and Methods
Materials. The following materials were purchased: Nonidet P-40 (NP-40), lactoperoxidase, glutaraldehyde (Sigma Chemical Co., St. Louis, MO); Na~SI and Bolton-Hunter reagent (New England Nuclear, Boston, MA); Ficoll-Hypaque (Pharmacia Fine Chemical, Piscataway, NJ), cyanogen bromide (CNBr) (Eastman Kodak Co., Rochester, NY), N,Ndimethyiformamide (Aldrich Chemical Co., Milwaukee, WI), polyethylene glycol (PEG) (PEG 6000; Fisher Scientific Co., Pittsburgh, PA), and RPMI and other tissue culture reagents (Gibco Laboratories, Grand Island, NY).
Purified Proteins. Highly purified Clq.was isolated according to a method previously described (25) and the protein concentration determined either by the method of Lowry et al. (26) or by measuring the optical density at 280 nM and using an extinction coefficient E~cm of 6.8. The homogeneity of a representative preparation of C 1 q used in these studies is shown in Fig. I .
Radioiodination of Proteins. All radiolabeled proteins were labeled with lesI by the Boiton-Hunter method as described (27) unless otherwise specified. Typically, 100 ~g of isolated protein in 0.1 M sodium borate buffer (pH 8.5) were added to 100/~Ci of Bolton-FIGURE 1. SDS-PAGE (7%) analysis of highly purified human Clq. Each gel contained 20 t~g of protein. Unreduced human Clq consists of six A-B dimers and three C-C dimers that upon reduction yield equimolar amounts of three chains designated A, B, and C.
Hunter reagent and allowed to react for 30 min at 4°C. The reaction mixture was then dialyzed against phosphate-buffered saline (PBS), pH 7.0, at 4°C until the dialysate was free of 12SI.
Preparation of Clq-Sepharose 4B. Highly purified Clq was coupled to Sepharose 4B according to the method described by March et al. (28) . Briefly, 50 mi of packed Sepharose 4B was washed extensively with deionized water and resuspended in 50 ml of 5 mM potassium phosphate tribasic buffer, pH 12.5 and stirred in an ice bath kept in a fume hood for 15 min. Then 7 g of CNBr dissolved in 3.5 ml of N,N-dimethylformamide were quickly added and the mixture was stirred for 5 rain. The Sepharose beads were then washed in a Buchner filter funnel in the fume hood with 2 liters of water followed by 2 liters of coupling buffer consisting of 8 g NaHCOs, 29.2 g NaCI/1, pH 9.0. The CNBractivated Sepbarose was mixed in a wide-mouth, 250-ml plastic bottle with 50 ml of human Clq (2 mg/ml) that had been dialyzed against coupling buffer, and the mixture was left for 16 h at 4°C with continuous stirring, after which it was placed in a Buchner funnel and evacuated to dryness. The amount of protein coupled to the Sepharose was determined by assaying the protein content in the filtrate. The Clq-Sepharose was then washed with 1 liter of PBS, pH 7.0 and resuspended in 50 ml of 1 M glycine, pH 8.0 for 2 h at 22°C to block the unreacted sites on the Sepharose beads. The slurry was washed by filtration with 1 liter of 5 mM sodium phosphate buffer, pH 7.5, containing 0.5 mM EDTA, 150 mM NaC1, and 0.02% NaNs, and poured into a 1.5 x 20 cm column. Before each use, the Clq-Sepharose column was tested for its activity by taking 0.5 ml of packed beads and incubating them with 0.2 m] of monospecific, polyclonal antiserum to Clq for 1 h at 4°C. After incubation the mixture was centrifuged (500 rpm, 5 min) and the remaining anti-Clq activity of the supernatant tested by Ouchterlony analysis, as shown in Fig. 2 .
Lymphoblastoid Cell Line. The cell line, Rail, used in this study was taken from a continuous culture line propagated in RPMI containing 10% fetal calf serum and 1% antibiotic-antimycotic mixture and was originally derived from a patient with Burkitt's lymphoma (29, 30) .
Purification of Clq Receptor. The purification of ClqR was essentially the same as that described earlier (24) with only minor modifications. Briefly, 3 x 109 Raji cells were washed three times and resuspended in 100 ml of 5 mM sodium phosphate buffer, pH 7.5, containing 0.5 mM EDTA, 150 mM NaCl, 10 mM EACA, and 0.5 mM phenylmethylsulfonyl fluoride (PMSF). Cell membranes were prepared by freeze-thawing (five times) at -8 0°C and centrifugation for 1 h at 30,000 g at 4°C. The pelleted membranes were then solubilized by suspension in 50 m] of the above buffer containing 1% NP-40 and stirred for 20 h at 4°C. The solubilized membrane proteins were freed from insoluble material by centrifugation at 30,000 g for 60 min at 0°C and the total protein concentration was determined to be 30 mg. After dialysis against 5 mM NaPO4 buffer, pH 7.5, containing 0.5 mM EDTA, 20 mM NaCI, 10 mM EACA, 0.5 mM PMSF, and 0.1% NP-40, 10 mg of the dissolved membrane solution was applied to a 1.5 x 20 cm C l qSepharose 4B column that had been equilibrated with the same buffer. The column was then washed with 600 ml of the starting buffer and the specifically bound proteins eluted with a linear NaCI concentration gradient with 300 ml of starting buffer and 300 ml of same buffer containing 1 M NaCI. Fractions containing Clq-binding activity were deter-FIGURE 2. Depletion of anti-Clq activity on a Clq-Sepharose 4B column. A sample of a monospecific, polyvalent antibody to C I q was incubated with C 1 q-coated Sepharose. Depletion of anti-C I q was another means of showing that the Sepharose beads were coated with the C 1 q offered. mined by single or double immunodiffusion techniques in a 0.8% agarose (sodium phosphate buffer, pH 7.2) containing 1.5% PEG 6000, using highly purified human Clq as described earlier (24, 31) , and concentrated on an Amicon pressure filtration device with a Diaflow UM-10 ultrafiltration membrane (Amicon Corp., Danvers, MA). When the ClqR was used in a hemolytic assay, the detergent concentration was always reduced to ~0.01% by passage through a column of QAE-50 Sephadex as described (24) .
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) Analysis of
ClqR. After radiolabeling with Bolton-Hunter reagent (27) , the isolated ClqR was reduced and aikylated by boiling for 5 min in the presence of 0.1 M dithiothreitol (DTT) and 0.2 M iodoacetamide and was analyzed by application on a 1.5-mm thick, 5-10% acrylamide gradient containing slab gels, using the method of Laemmli (32) . After electrophoresis, the gel was stained with Coomassie Blue, vacuum-dried, and analyzed by autoradiography.
Ultracentrifugation Analyses. Ultracentrifugation analysis of isolated ClqR was determined on a 5-40% sucrose-containing linear gradient in 5 mM NaPO4 buffer containing 90 mM NaCI, 10 mM EACA, 0.5 mM EDTA, 0.5 mM PMSF, and 0.1% NP-40, pH 7.4. Centrifugation was carried out in a Beckman model L5-75B ultracentrifuge (Beckman Instruments, Inc., Fullerton, CA) using an SW65 rotor for 20 h at 50,000 rpm. Clq (1 IS), C3 (9.5S), albumin (4.6S), and cytochrome c (1.7S) were used as markers.
In another set of experiments, an equilibrium density gradient uitracentrifugation was run in the following manner. First, the isolated ClqR was dialyzed overnight at 4°C against distilled water and then lyophilized. The dried residue was then dissolved in 8 ml of a solution comprised of 4 M guanidinium chloride, 0.05 M sodium acetate, pH 5.8, Nethyl malimide, 0.1 M EDTA, 0.1 M EACA, and 0.005 M benzamidine, that contained cesium chloride to a density of 1.5 g/ml. The solution was centrifuged at 12°C for 72 h at 100,000 rpm in a Beckman ultracentrifuge using a swing-out rotor (SW60). The tubes were then frozen in liquid nitrogen and cut into two fractions: the bottom 2/5 and the bottom 3/5 by volume. The fractions were then dialyzed against 0.2 M sodium acetate, pH 5.8 and then against distilled water at 4°C. Finally, the material was lyophilized and then dissolved in 1.0 ml of distilled water. Protein and uronate were determined on an autoanalyzer (Techicon Instruments Corp., Tarrytown, NY).
Amino Acid Analysis. Amino acid analysis was performed with an amino acid analyzer (model 121M; Beckman Instruments, Spinco Division, Palo Alto, CA) equipped with an automatic sample injector and a model System AA automatic digital integrator. The sample was hydrolyzed in 6 N HCI for 20 h at 110°C in evacuated and sealed Pyrex tubes. ~25 nmol of hydrolyzed protein were applied to each column and the amino acid concentration was determined by comparison with a standard mixture of amino acids (100 nmoi/ml).
Effect ofChondroitinase ABC on ClqR.
To determine the effect ofchondroitinase ABC, 0.1 #g purified 125I-C 1 qR was dissolved in 0.1 ~i of Tris-HCi, pH 8.0, and incubated with buffer alone or with 0.1 U of enzyme as described previously (31) for 12 h at 37 °C. Then the sample was dialyzed against buffer containing 0.14 M Na2SO4, 0.01 cacodylic acid, and 0.1% NP-40. The chondroitinase-digested sample and the control sample were sequentially applied to a column of Sepharose CL-6B (0.5 × 120 cm; matrix, 108 cm) equilibrated with same buffer together with 250 ~g of bovine nasal cartilage proteoglycan AIDI (Vo marker, =2.2 × 106 mol wt) and 20 #g glucuronolactone (Vt marker, =176 mol wt) and eluted with the same buffer at a flow rate of 5 ml[h. Fractions were analyzed by Ouchterlony using isolated C 1 q and by the carbazole method of uronic acid determination (33) .
Inhibition of EClq Rosettes by ClqR or Monoclonal Antibody to ClqR. The ability of
ClqR to inhibit Clq-dependent rosette formation was determined by a previously described rosette assay (34, 35) and consists of the following steps. First, human erythrocytes (Eh) were treated with 100 voi of 2% glutaraldehyde in 0.15 M PBS, pH 7.4, at 4°C for 16 h. The cells were washed with Hanks' balanced salt solution (HBSS) and further incubated with 10 vol of HBSS containing 10 mg/ml L-lysine for 30 min at 37°C, after which the cells were washed and resuspended in HBSS at 1 × 109/ml. Then 5 × 108 cells in 1 ml HBSS were incubated with 200 t~g Clq and a tracer amount (1/~g) of t2sI-Clq (8 × 105 cpm/ug). The excess unbound C 1 q was removed by centrifugation in HBSS. Rosette formation was then assayed by incubating 1.5 × 107 Eh Clq with 5 × l0 s Raji cells in a total volume of 0.4 ml HBSS for 5 min at 37°C, centrifuging for 5 min at 600 rpm, and further incubation for 60 min at 4°C. To determine the inhibitory effect of isolated ClqR, the Raji cells were either pretreated with 5 t~g/mi F(ab')~ or the reaction mixture was incubated in the presence of 5 gg C I qR. The percent rosettes formed was determined by counting at least 100 lymphocytes in a microscope (Microstar; American Optical Scientific Instruments, Buffalo, NY).
Clq-dependent CytotoxicityAssay. 51Chromium-labeled, Clq-coated chicken erythrocyte target cells (5~Cr-F~) were prepared as described earlier (15) . The inhibitory effect of ClqR was tested by preincubating 10 ug ClqR with 8 × 104 5~Cr-~ and leaving the excess unbound ClqR in the reaction mixture, which contained, in addition, 2 × 10~Raji cells in a total volume of 0.4 ml of RPMI containing 0.4 human serum albumin, 2 mM Lglutamine, and 1% antibiotic-antimycotic mixture (penicillin 10,000 U/ml, fungizone 25 t~g/ml, streptomycin 10,000 mcg/ml). Incubation was carried out at 37°C in a CO2 incubator for 20 h. After incubation, the reaction mixture was centrifuged for 10 rain at 1,000 rpm, the radioactivity of both pellet and supernatant determined, and cell damage expressed as the percentage of the total radioactivity released from the cell into the supernatant.
Effect of lsolated ClqR on Clq Hemolytic Function.
There is evidence in the literature indicating that the Clq receptor reacts with the collagen-like region of the molecule (16, 24) . Since this region also constitutes the site to which Clr and Cls bind, an experiment was performed to see if the isolated molecule could inhibit the hemolytic activity of C1 in serum. This was determined by incubating 5 #g/ml of purified ClqR (which had been repurified on a QAE-Sephadex column to reduce the detergent concentration) with or without 50 ng of Clq for 60 min at 37°C, followed by an additional 60 min incubation in the presence of 10 ul of C1 q-depleted serum (containing 20 mM CaCI~) and antibodysensitized sheep erythrocytes (EA) (5 × 10S/ml) in a total volume of 0.5 ml GVB (veronalbuffered saline containing 0.15 mM CaCl~, 0.5 mM MgCI2, and 0.1% gelatin) (24) . After incubation, the cells were centrifuged and the amount of hemoglobin released into the supernatants was determined spectrophotometrically at 700 nm. The inhibitory effect of the isolated substance was expressed as the percent inhibition of C 1 q hemolytic activity.
Results
Purification of CIqR by Affinity Chromatography. When a total of 10 mg of unlabeled and tracer amount (1 X 108 cpm/#g) of surface-labeled, NP-40-solubilized Raji cell membranes were chromatographed on a Clq-Sepharose 4B column and bound proteins eluted with a linear NaCI concentration gradient, two discrete, Clq-reactive peaks eluted at approximately 22 and 30 mmho/cm, respectively (Fig. 3) . This seems to suggest that Raji cells possess two species of receptors with different affinities or charge heterogeneity. The two peaks were then separately pooled, concentrated, and designated arbitrarily as C 1 q receptor I and I! (ClqRI and -II). From the tracer amount of radiolabeled protein incorporated, it was determined that the two C lq-reactive proteins represent -7% of the total labeled Raji cell membrane proteins.
Immunodiffusion Analysis oflsolated CIqR. Equal concentrations of the pooled and concentrated peaks, C1 qRI and C l qRII, were tested for their ability to bind and precipitate Clq using double (Fig. 4A) and single (Fig. 4B) immunodiffusion techniques. Both pools were found to be reactive, although the precipitation ring obtained by ClqRII (Fig. 4B ) was apparently stronger than that for ClqRI, probably due to the disparity in concentration, since ClqRII was found to contain at least two other protein bands (see below). Furthermore, ClqR was found to react with normal human serum (NHS) that contains EDTA but not NHS alone, indicating that under physiologic conditions where C 1 q is in complex with Clr2 and Cls2, the receptor does not bind to Clq in NHS.
SDS-PAGE Analysis of ClqR.
Both ClqRI and ClqRII were radiolabeled with ~sI and analyzed on a 10% SDS gels. As shown in Fig. 5 , both ClqR preparations contained a major band (80-90 kD) that, under reducing conditions, resulted in a single, 60-70 kD band. However, while ClqRII was relatively homogeneous, ClqRI was found to contain at least two distinctly visible bands that together represented ~50% of the preparation. It is also of interest that the ClqR molecule has a much more pronounced 1251 band upon reduction than without reduction, indicating that the protein moiety might exist as a polymeric structure of disulfide-bonded 70,000 mol wt chains. Furthermore, some visible bands were observed at the top of the gel, and two or three protein bands were visible that did not label with ~5I.
Ultracentrifugation Analysis. Sucrose density ultracentrifugation analysis revealed that the ClqR sediments at -4.2 S; the results of one such experiment is shown in Fig. 6 . In addition, equilibrium density gradient uhracentrifugation showed that the isolated receptor could be separated into a protein-rich, low density fraction and a carbohydrate-rich, high density fraction (Table I) . The large hydrodynamic size, coupled with the high buoyant density and uronic acid content, suggests that a proteoglycan is a constituent of the complex.
Amino Acid Analysis. The results of amino acid analysis data are represented in Table II . One of the striking features is that ClqR is rich in glycine, with glutamic acid and aspartic acid following closely behind, which explains its acidic nature. The hexosamine ratio, or the ratio of galactosamine to glucosamine, was found to be 3.2. Furthermore, the uronic acid content of a typical ClqR preparation was found to be 23%, while galactosamine content was 21%.
Digestion of ClqR with Chondroitinase ABC. Previous studies postulated that
the plasma-derived C 1 q inhibitor, which was identified as a chondroitin 4-sulfate proteoglycan (31) , and the lymphocyte membrane-derived C lq inhibitor (C lqR), could be similar or identical. To assess this issue, an experiment was designed in which the C l q R was incubated with either buffer or chondroitinase ABC, as described in Materials and Methods. Both materials were then applied to a CL-6B column (0.5 x 120 cm; matrix height, 105 cm). After elution, it was found that the treated and untreated C l qR chromatographed in the same region, with a Kay of 0.45 (Fig. 7) , indicating that ClqR is not digestable with chondroitinase. Furthermore, chondroitinase-digested C 1 qR did not lose its ability to precipitate Clq as assessed by a double radial immunodiffusion analysis, as described.
Inhibition of C l q-dependent Biological Functions by C I qR.
The ability of isolated C l q R to inhibit Clq-dependent rosette formation was tested by preincubating glutaraldehyde-treated, Clq-coated Eh with or without 5 #g/ml of the receptor and then with either peripheral blood lymphocytes that had been purified by centrifugation on Ficoll-Hypaque (36) or Raji cells for 60 min at 4°C. As shown in Table III , 5 #g/ml of ClqR was able to inhibit rosette formation. Furthermore, FIGURE 5. SDS-PAGE gel analysis of Clq-Sepharose pools. The pooled fractions in Fig. 3 were concentrated and radiolabeled before further purification. The specific activity was 7.7 x 10 s and 5.1 x 10 s cpm/#g for pool I (ClqRI) and pool II (ClqRII), respectively. ~5 X 104 cpm (~7 #g) of each sample was applied to a Laemmli slab gel (10%) in the absence (I and 3) or presence (2 and 4) of 0.1 M DTT. After electrophoresis the gel was stained with Coomassie Blue, vacuum-dried, and exposed in a Dupont Cronex cassette with Lightning Plus screens for 24 h at -80°C before autoradiographic analysis. both the C 1 q-dependent cellular cytotoxicity (Table IV) and hemolytic functions (Table V) were found to be inhibited by C l q R .
Discussion
In previous reports (23, 24) we isolated a lymphocyte membrane-associated C 1 q precipitin (23) or M-C 1 q inhibitor (24) and demonstrated that it was capable of inhibiting some of the C 1 q-dependent biological functions. T h e questions that arose from these studies were: (a) What is the exact chemical nature of the membrane-derived C l q inhibitor? (b) What is its relationship to the plasma C l q inhibitor? and (c) Is the C l q inhibitor identical to the C l q receptor on lymphocytes? T o answer these questions and further characterize the chemical, as well as the functional nature, the membrane-associated inhibitor was isolated to homogeneity using a C l q -S e p h a r o s e 4B affinity column as described earlier (23) . T h e present results clearly demonstrate that the isolated C l q inhibitor constitutes the cellular receptor for C l q and that it may exist as two distinct populations of receptors possessing different affinities for the C lq molecule. * A lyophylized preparation of CIqR that had been dissolved in 4 M guanidinum chloride, containing 0.05 M sodium acetate, pH 5.8, Nacetyl maleimide, 0.1 M EDTA, 0.1 M amino-caproic acid, 0.005 M benzamidine, and 1.5 g/ml cesium chloride, was centrifuged at 12°C for 72 h. The fractions were collected by freezing the tubes and cutting. Protein and uronate were determined on a Technicon autoanalyzer.
This conclusion is derived from the observations that when the detergentsolubilized membrane proteins were applied to the C 1 q-Sepharose 4B column, washed exhaustively, and the adsorbed materials eluted, two discrete peaks eluting at different ionic strengths (22 and 30 mmho/cm, respectively) were obtained. Both species had similar properties since both were capable of binding The percent total sample on the column is 67.28; total nanomoles of amino acids, 97; total micrograms of protein, 11.6. Hexosamine ratio: glucosamine/galactosamine, 0.3; galactosamine]glucosamine, 3.2.
and precipitating free C 1 q, although the concentration of C 1 qRI (after further purification) required to precipitate the same amount of C l q was one-half that of pool II. However, the conclusion that two distinct cell receptor populations might exist should await binding studies to determine their affinity constants. C 1 q possesses two binding sites for certain types of mucopolysaccharides such as low molecular weight heparin (37); the high affinity-binding site was shown to be the collagenous region of the molecule. That the Clq inhibitor is a cellular receptor for Clq (ClqR) is inferred from the following lines of evidences. (a) When the isolated material or C 1 qR was preincubated with C 1 q-bearing, glutaraldehyde-treated Eh, no rosette formation was obtained upon subsequent incubation with lymphocytes or Raji cells. (b) Clq-coated, 51Cr-labeled chicken erythrocyte target cells were prevented from lysis by Raji cells when the target cells were first preincubated with the C lqR. That this complement-mediated cellular cytotoxicity (CDCC) is mediated by the effector celI-C l q receptor has been previously documented (15) . * Rosettes were formed by incubating 0.2 ml peripheral blood lymphocytes (PBL) or Raji cells (2.5 X 108/ml) with 1.5 X l0 T Clq-coated (15 #g) glutaraldehyde-treated human erythrocytes (EC I q) in a total volume of 0.4 ml HBSS for 5 min at 37°C, centrifuging 5 min at 600 rpm, and further incubating for 60 min at 4°C. * Inhibition of EC I q rosettes by C l qR was determined by preincubating EClq with 5 #g/ml CIqR for 15 min at 37°C before incubation with lymphocytes or lymphoblastoid cells.
the binding of Clq. (e) Furthermore, murine F(ab')2 monoclonal antibody to ClqR was found to inhibit 12~I-Clq binding to Raji cells. ~ The Clq molecule is collagen-like with six globular heads that are the binding sites for Ig. The collageneous tail of the molecule is considered to be the site where Clr and Cls bind in plasma. The collageneous region of the molecule constitutes the site through which C l q binds to receptors (14) (15) (16) (17) . Our finding that ClqR was unable to precipitate Clq in serum seems to confirm these findings.
The results obtained from equilibrium gradient ultracentrifugation indicate x 105 Raji cells in the presence or absence of 5 t~g/ml ClqR in a total volume of 0.3 ml RPMI plus 5% FCS for 20 h at 37°C in an atmosphere of 95% air and 5% CO2. After incubation, cells were centrifuged and the radioactivity of both pellet and supernatant determined. Cell damage is expressed as percent of total radioactivity released from the cells into the supernatant. that a proteoglycan constitutes a part of the complex. However, amino acid analysis together with the glucosamine-to-galactosamine ratio and the insensitivity of the C 1 q receptor to digestion with chondroitinase seem to distinguish the C 1 q receptor from the serum C 1 q inhibitor, which has been previously characterized as chondroitin 4-sulfate proteoglycan (31) . It is likely, however, that the C 1 qR and serum C 1 q inhibitor represent functional counterparts, in as much as both macromolecules are able to inhibit most of the Clq-dependent biologic reactions (23) . Upon electrophoresis on SDS gels, the C 1 qR was shown to consist of a single protein band of 80-90,000 mol wt which, upon reduction, stains heavier, with a single band of ~60-70,000 mol wt. The ultracentrifugation data and the SDS-PAGE profile taken together suggest that the ClqR is a polymeric structure consisting of a protein portion noncovalently linked to a proteoglycan. The biological significance of the receptor cannot be determined from these studies. It is clear, however, that the receptor does bind only to free C 1 q. Upon activation of the classical pathway of complement by immune__ complexes, cT-INA, the plasma inhibitor of activated C1, binds to Clr and Cls to form an irreversible complex, and thus readily dissociates them from the C 1 q molecule. Under these conditions, the collageneous tail of the Clq molecule becomes exposed and possibly available to bind to cell surface receptors on monocytes, iymphocytes, or polymorphonuclear cells (PMN), though this type of Clq is believed to be conformationaily changed (38) . Whether binding of a Clq-containing immune complex to a phagocytic cell Clq receptor represents one mechanism of immune clearance remains to be investigated. The binding of free Clq to cells possessing receptors for Clq promotes biological functions, as is apparent from studies which found that ~lCr-labeled, Clq-Ec could be lysed by Raji cells as well as by lymphoblastoid cells in the absence of anti-target cell antibody (15) . This C l q-mediated cellular cytotoxicity could be inhibited if the C lq-coated target cells were first pretreated with ClqR (15) . In addition, Clq has been reported (18) (19) (20) to inhibit collagen-dependent platelet aggregation and serotonin release. Whether this inhibition is mediated by a specific platelet receptor for Clq or if the platelet recognizes the collagen portion of the Clq through a specific receptor for collagen is not clear. The C l q receptor isolated from Raji cells is similar if not identical to the receptor on PMN or platelets, as has been confirmed through immunoprecipitation studies using C lq-coated Sepharose beads and murine monoclonal antibody raised to the receptor (manuscript in preparation). More work is needed to determine the precise function of cellular C I q receptor.
TABLE V

Reduction of C l q Hemolytic Activity by C l qR
Summary
We have shown previously that an activity which is capable of precipitating purified C l q and inhibiting some of the C1 q-dependent biologic reactions could be solubilized from the membranes of both normal human peripheral B lymphocytes and a B cell-derived lymphoblastoid cell line (Raji), both of which are known to possess receptors for human C l q. In this report we present evidence that this membrane-associated Clq inhibitor is a chondroitinase-insensitive macromolecule and is the receptor for human C lq. The receptor was solubilized from membranes of Raji cells with Nonidet P-40 and purified to homogeneity using C 1 q-Sepharose 4B affinity chromatography. Equilibrium density gradient centrifugation analysis revealed that the complex could be resolved into a proteinrich, low density fraction and a carbohydrate-rich, high density fraction. The large hydrodynamic size, coupled with the high buoyant density, suggests that a proteoglycan is a constituent of the complex and indicates that the receptor might be a macromolecular complex of a proteoglycan portion noncovalently linked to a 60-70 kD glycoprotein. The glycoprotein moiety, in turn, consists of two or more identical (70,000 mol wt) polypeptide chains held together by disulfide bonds and constitutes the Clq receptor (ClqR). Sucrose density ultracentrifugation analysis showed that the isolated receptor sediments with an apparent rate of 4.2 S. Immunochemical analyses demonstrated that a typical preparation of the ClqR complex consists of -23% uronic acid and ~21% galactosamine with a galactosamine-to-glucosamine ratio of 3.2. Binding of C l q to the receptor was found to be optimal at low ionic strength and neutral or near-neutral pH (7-7.4). The isolated receptor was found to inhibit Clq hemolytic function, abrogate C l q-dependent rosette formation, and block the C l qdependent, cell-mediated cytotoxicity, all of which are activities mediated by the receptor.
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